Just Other Articles

Become the Manager Who is a Failure at Managing Meetings

Meetings have become an inevitable part

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

of doing business for almost every department owner. There are meetings with clients, meetings with employees and meetin

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

gs with peers or associates. Almost everyone has suffered through too many meetings that take up too much time and accomp

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

lish too little. In fact, you may find that you yourself have now become numb to the fact that your meetings aren’t as go

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

od as they could be. And everywhere you look, it seems as if somebody has another idea about how to fix your meetings, an

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

make them more focused, more productive, and – dare I say it? More fun! So what can you do about it? Relax and keep read

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ing, because you’re about to find the information that can help you maintain the status quo – a list of tips and ideas fo

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

r meeting planning – the wrong way!

1. Schedule your meetings at bad times - (for example, how about setting up a “must

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

attend” meeting late on Friday afternoon?).

2. Make sure your meetings all start late and run overtime - (and whenever p

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ossible, scheduling meetings when someone is up against a deadline, or on a tight schedule).

3. Maintain a consistent la

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

k of focus on what topics will be covered – (don’t use an agenda).

4. Ensure there is a poor level of rapport in the gro

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

up – (people don’t talk to each other, or they complain, or engage in other unsuitable behaviour).

5. Don’t arrive at a

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

decision - (find new ways to keep covering the same ground, or continue asking for input rather than creating a plan of a

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ction.)

6. Choose a poor location and environment for your meetings - (for example, trying to fit 15 people into a close

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

t-sized room that doesn’t have windows or a proper ventilation system.)

7. Schedule meetings to go over routine topics -

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

(instead of sending a memo or email.)

8. Don’t talk to your group, or make your meetings interactive - (talking “at” the

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

m, lecturing or going off on wild tangents.)

9. Never asking for feedback from participants, or allowing others to prese

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

nt ideas or get involved.

There you have it! Just follow those nine simple tips, and you're guaranteed to instill fear,

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

loathing and boredom into even the most intrepid of meetings.

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Just Other Articles - Be A Failure At Managing Meetings - Read This And Make Sure You Do The Opposite

Related Articles: